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1. Introduction
Pulpotomy is still the most frequent endodontic treatment
performed on primary molars.1–6 This treatment is defined as
‘‘a procedure that involves the amputation of the coronal
portion of the affected or infected dental pulp’’.7 It is indicated
in primary teeth with inflammation of the coronal pulp caused
by caries with no involvement of the radicular pulp.7
Formocresol remains the most widely used pulpotomy
medicament on primary teeth. Its mummifying action is
undisputed, but concerns have been expressed given its toxic,
carcinogenic and mutagenic potential.8,9
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Objectives: The aim of the present study was to conduct a clinical and radiographic long-
term evaluation of pulpotomy in temporary molars performed with Grey and White Mineral
Trioxide Aggregate (MTA) and compare the results of Grey and White MTA pulpotomies in a
sample of 233 primary molars with a maximum follow-up period of 84 months.
Methods: The sample was selected from patients treated at the Department of Pediatric
Dentistry, Faculty of Dentistry, Complutense University of Madrid, Spain. This prospective
study included first and second primary molars treated with pulpotomy with Grey or White
MTA, controlled for a maximum follow-up period of 84 months. Statistical analysis of
clinical and radiographic findings was completed using ANOVA (P < 0.05).
Results: Follow-up evaluations, performed every 6 months, revealed that only 2 molars
treated with White MTA presented abscess and pathological mobility. Radiographic exami-
nation of the 210 molars revealed unfavourable pulp response in only 6 molars (internal or
furcation root resorption), without statistically significant differences between Grey and
White MTA. Two radiological findings were noticed: dentine bridge formation and partial or
total root canal stenosis. Grey MTA induced a higher percentage of dentine bridges with
statistically significant differences (P < 0.05), and a higher percentage of pulp canal stenosis,
without a statistically significant difference.
Conclusions: Grey and White MTA presented high levels of clinical and radiographic success.
Although the present study showed evidence of a very good biologic response with both
types of MTA, Grey MTA showed significantly higher number of dentine bridge formation
than White MTA.
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Many alternatives to formocresol have been proposed.
One alternative seems to be Mineral Trioxide Aggregate
(MTA) as it is a more biologically acceptable product. It was
first described in the dental scientific literature by Lee et al.
in 199310 and patented in 1995 by Torabinejad and White.11
In 1998 it was approved by the US Food and Drug
Administration as a therapeutic endodontic material for
humans.12,13
MTA is a mixture of a refined Portland cement, composed
by dicalcium silicate, tricalcium silicate, tricalcium aluminate,
gypsum and tetracalcium aluminoferrite. It also presents
bismuth oxide which makes it radiopaque.14–18
In vitro and in vivo investigations have shown that MTA has
many properties such as excellent biocompatibility, an
alkaline pH, radiopacity, a high sealing capacity and the fact
that it hardens in the presence of humidity 2–4 h after mixing.
MTA can also induce the formation of dentine, cement and
bone.19–22
When MTA was first commercialized it had a grey
colouration but in 2002 a new formula was created, the White
MTA, to improve on the dark colour properties exhibited by
Grey MTA.
In recent years many studies have been published on the
use of MTA in permanent teeth. Its use in primary teeth is
much more limited and mainly used as a pulp dressing agent
in pulpotomy treatments.23 Results have shown a very high
clinical and radiographic success rate but clinical long-term
studies are scarce regarding primary teeth. A previous study
evaluated a total of 69 primary molars treated with Grey MTA
with a maximum follow-up of 42 months, as well as 13
primary molars treated with White MTA reviewed 6 months
after treatment.24 Holan et al. investigated MTA effects in 33
pulpotomized molars during a medium follow-up evaluation
period of 38.2 months26 reporting a success rate of 97%; Naik
and Hegde evaluated 25 pulpotomized molars for a period of 6
months showing a success rate of 100%27; Farsi et al. compared
the effect of MTA in 60 pulpotomized molars to those of
formocresol, followed during 2 years28 noting a success rate of
100%.
The aim of the present study was to conduct a clinical and
radiographic long-term evaluation of pulpotomy in temporary
molars performed with Grey and White MTA and compare the
results of Grey and White MTA pulpotomies in a sample of 233
primary molars with a maximum follow-up period of 84
months.
2. Materials and methods
The sample of this study was selected from the patients
attending the clinic of the Department of Pediatric Dentistry,
Faculty of Dentistry, Complutense University of Madrid, Spain,
between 2001 and 2009.
This prospective study was designed to include first
and second primary molars that had been treated
by pulpotomy with Grey or White ProRoot1 MTA (Tulsa
Dental Products, Tulsa, OK, USA). The authors had been
previously involved in several pulpotomy studies and used a
standardized technique. The inclusion criteria in the study
were:
1. Subjects with no systemic pathology or allergies;
2. Primary molars which needed a pulpotomy treatment due
to caries;
3. Primary molars revealing no clinical or radiographic signs
of radicular pulp degeneration (i.e. abscesses, associated
fistulous tracts, increased mobility, furcation involvement,
internal or external pathological root resorption, or patho-
logical thickening of the periodontal membrane);
4. Primary molars which could be restored with stainless steel
crown;
5. Primary molars which had not been previously treated;
6. Primary molars presenting, at treatment time, at least half
of the root length;
7. Primary molars in which the operator strictly followed the
same protocol, described by Maroto et al.,25 performing the
pulpotomy:
(a) Complete isolation with rubber dam.
(b) Preparation of the molar and fitting of a stainless steel
crown.
(c) Removal of the carious tissue with a round bur.
(d) Elimination of the roof of the pulp chamber and removal
of the coronal pulp tissue with a large low speed round
bur.
(e) Drying and control of the pulp haemorrhage using slight
pressure with a sterile cotton wool pellet.
(f) Mixing of the MTA with sterile water on a glass slab
following the manufacturer’s instructions.
(g) Pressing the MTA to the walls and floor of the pulp
chamber with a cotton wool pellet moistened in sterile
water.
(h) Filling the pulp chamber with light-curing glass-
ionomer cement.
(i) Cementation of the stainless steel crown with self-
curing glass-ionomer cement.
The sample consisted of 233 primary molars (98 maxillary
molars and 135 mandibular molars). Twenty-three molars
were not included in the study as they belonged to patients
who did not show up to follow-up visits. Therefore, our final
sample included 210 primary molars:
- Molars treated with Grey MTA: 33 maxillary molars (18 first
molars; 15 second molars) and 41 mandibular molars (20 first
molars; 21 second molars).
- Molars treated with White MTA: 57 maxillary molars (28 first
molars; 29 second molars) and 79 mandibular molars (38 first
molars; 41 second molars).
Follow-up time ranged between 6 and 84 months.
Prior to the beginning of the study, approval from the ethics
committee of the Clinical Hospital of San Carlos, Madrid, Spain
(#P-05/346) and parental informed consent was obtained. Also,
calibration between the examiner and the evaluator was
performed.
The same data were collected by the examiner and the
evaluator separately, following the same criteria, in order to
evaluate the agreement between the result readings and
involved clinical and radiographic examination of each
treated molar and its radicular area. The UCM Research
Support Service (RSS) evaluated concordance between exam-
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iners through the use of Kappa index (k = 0.93; P < 0.05). The
treatment was considered a failure if one or more of these
signs were observed: inflammation, abscess or fistula in the
soft tissues, pathological mobility, spontaneous pain or due to
percussion, pathological thickening of the periodontal mem-
brane, or dissolution of the MTA.
During radiographic examination, reparative dentine de-
position, the number of dentine bridges, and the presence of
pulp canal stenosis were recorded. To correctly calculate this
deposition, only the mandibular molars were taken into
account because radiographic superimposition due to the
presence of three roots in maxillary molars would result in
false positives.
Statistical analyses of the results of clinical and radio-
graphic evaluation were completed using SPSS 17.0 Software
(SPSS Inc., Chicago, IL, USA). The Kappa index was performed
to determine variations within and between examiners. A
descriptive analysis was performed to obtain frequencies and
percentages of clinical and radiographic response, as well an
ANOVA of repeated measures with Greenhouse–Geisser
correction. Statistical significance was established for P < 0.05.
3. Results
Kappa index revealed agreement between data collected from
the examiner and the observer (k = 0.93); therefore, the data
collected by the examiner were used for the statistical
analysis.
3.1. Clinical evaluation
Six months after treatment signs of clinical success were
found in all treated molars. Successive follow-up evaluations,
performed every 6 months, revealed 2 molars treated with
White MTA presented abscess and pathological mobility: a
first right upper primary molar (54) after 12 months and a
second right upper primary molar (55) after 36 months. Both
molars were extracted.
3.2. Radiographic evaluation
MTA remained in the pulp chamber of all molars without
showing any signs of resorption or displacement over time.
Radiographic examination of the 210 molars revealed
radiographical signs of unfavourable pulp response in only
6 molars, mainly consisting of internal or furcation root
resorption. These molars were monitored until their physio-
logical exfoliation.
There were no statistically significant differences on the
radiographic signs of unfavourable pulp response between
molars treated with Grey and White MTA (P = 0.141).
3.3. Reparative dentine formation evidence
The periodic radiographic follow-up examinations revealed
two kinds of findings considered as signs of a favourable pulp
response: dentine bridges in the area immediately below the
MTA (Fig. 1), and partial or total radicular pulp canal stenosis
(Fig. 2).
The total number of root canals studied for this purpose
was 240: 82 treated with Grey MTA and 158 treated with White
MTA, monitored every 6 months for a maximum period of 84
months (Table 1).
Dentine bridges were already present in 31.7% of the canals
after 6 months of treatment with Grey MTA. This percentage
increased as the evaluation time increased reaching 100% of
the sample reviewed at the end of the study (84 months). In
order to compare the existence of differences and similarities
between left and right molars as well as between first and
second temporary molars a statistical adjustment was made
and molars with a follow-up time of at least 30 months were
selected. Through this analysis it was possible to evaluate
differences between percentages and behavioural profile
throughout time, which were not statistically significant in
the group of molars treated with Grey MTA. Nevertheless, it
[()TD$FIG]
Fig. 1 – (a) Radiograph obtained 8 months after treatment
with Grey MTA indicating the dentine bridge and (b)
radiograph obtained 16 months after treatment with
White MTA indicating the dentine bridge.
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was observed that the presence of dentine bridges increased
with time; as the contact time between MTA and the radicular
pulp increased, dentine deposition was more frequently
observed.
Dentine bridges were present in 18.5% of the root canals
after 6 months of treatment with White MTA, in 50% after 30
months and in 83.3% after 54 months. The comparative
analysis revealed that in this case there were no statistically
significant differences between percentages and behavioural
profile throughout time as for Grey MTA, but, once again, time
significantly influenced the appearance of dentine bridges.
The distribution of observed dentine bridges in molars treated
with Grey and White MTA is presented in Table 2.
Stenosis of the radicular pulp canals was present in 14.6%
of the canals treated with Grey MTA 6 months after treatment,
57.1% after 12 months and 86.4% after 24 months. At the end of
the study, 84 months, every canal treated with Grey MTA
presented stenosis. The comparative analysis revealed that
there were statistically significant differences between beha-
vioural profile throughout time for left lower molars and right
lower molars but no differences between percentages of
radicular pulp canal stenosis.
Molars which have been treated with White MTA presented
stenosis in 24.7% of the root canals 6 months after treatment,
in 54.2% after 12 months, 79.7% after 30 months and it was
after 54 months that all the canals presented stenosis. The
comparative analysis revealed significant differences between
the percentages of stenosis observed on left and right first
molars, but no differences in the behavioural profile. The
distribution of observed root canal stenosis in molars treated
with Grey and White MTA is presented in Table 3.
Comparing the dentine bridge percentages observed in root
canals treated with Grey MTA with those treated with White
MTA, the authors observed that, in general, higher percen-
tages were obtained when Grey MTA was used. These
differences were statistically significant (P < 0.05).
A higher percentage of stenosis in the root canals treated
with Grey MTA was noticed, but without statistical signifi-
cance. There were no differences in the behavioural profile
between the two types of MTA.
4. Discussion
Since MTA has been used in pulpotomies of temporary molars,
clinical and radiological evidence-based success rates have
been demonstrated. In many scientific articles the authors
expressed the need for studies with larger samples and longer
follow-up periods; the present study far exceeds previously
published ones: 210 molars periodically evaluated for a
maximum of 84 months. Moreover, this study evaluated
and compared the two types of MTA: Grey and White.
The clinical success rate of molars treated with Grey MTA
in this study was 100%. This percentage coincides with the
results obtained in other investigations.23,27–32 Molars treated
with White MTA exhibited a clinical success rate of 93% as two
cases presented abscess and non physiological mobility.
Maroto et al.24 obtained a higher clinical success rate, 100%,
in a 6-month follow-up as did Noorollahian in a 24-month
[()TD$FIG]
Fig. 2 – (a) Radiograph obtained before pulpotomy
treatment and (b) radiograph obtained 42 months after
treatment with Grey MTAwhere root canal stenosis can be
observed.
Table 1 – Distribution of root canals radiologically
studied in each follow-up review to analyse dentine
bridges and pulp canal stenosis formation.
Time Total number of mandibular root canals
Grey MTA White MTA
6 months 82 158
12 months 70 144
18 months 70 114
24 months 66 90
30 months 60 74
36 months 50 58
42 months 38 32
48 months 32 20
54 months 30 6
60 months 24 2
66 months 20 0
72 months 16 0
78 months 16 0
84 months 10 0
j o u rn a l o f d e n t i s t r y 3 9 ( 2 0 1 1 ) 1 8 7 – 1 9 3190
Author's personal copy
follow-up. In contrast, Agamy et al.31 obtained a lower clinical
success rate, 80%, 12 months after treatment.
Other studies have reported that teeth treated with Grey
MTA presented colour changes after treatment.27,33 Al-
though we could not find in the scientific literature any
report of discolouration in teeth treated with White MTA, in
our daily practice we have also observed this phenomenon in
primary incisors, canines and molars. In the present
investigation, any discolouration that might have occurred
did not represent an aesthetic problem as all molars were
restored with a stainless steel crown, as recommended by
other authors.24 In this study it was decided to use stainless
steel crowns for two different reasons. First, the success of
pulpotomy treatments not only depends on the effect of the
material used, but is directly related to the ability of both
materials, filling and final restoration, to achieve a good
biological seal against immediate and long term microleak-
age. Also, the majority of human clinical investigations with
which we compared our study results, used preformed
stainless crowns.5,23,24,27,28,32,34
In the radiographic analysis performed every 6 months no
signs of displacement or resorption of the MTA was seen. None
Table 2 – Percentage of root canals presenting dentine bridges in each follow-up, distributed by molar and type of MTA.
Follow-up time Molar
74 75 84 85
% RC % RC % RC % RC
GMTA WMTA GMTA WMTA GMTA WMTA GMTA WMTA
6 months 20.8 19.4 26.9 19.6 62.5 22.5 50 11.1
12 months 37.5 47.1 66.7 42.9 62.5 50 41.7 34.4
18 months 45.8 46.9 72.2 47.1 62.5 59.1 41.7 38.5
24 months 50 50 72.2 38.5 75 50 58.3 38.9
30 months 55.6 54.2 81.3 40.9 85.7 66.7 58.3 43.8
36 months 62.5 65 91.7 50 85.7 60 60 58.3
42 months 66.7 75 90 40 80 25 83.3 66.7
48 months 80 70 90 37.5 100 – 100 100
54 months 87.5 75 90 100 100 – 100 –
60 months 83.3 100 100 – 100 – 100 –
66 months 83.3 – 100 – 100 – 100 –
72 months 75 – 100 – 100 – 100 –
78 months 75 – 100 – 100 – 100 –
84 months 100 – 100 – – – 100 –
% RC: percentage of root canals presenting dentine bridges.
GMTA: Grey Mineral Trioxide Aggregate.
WMTA: White Mineral Trioxide Aggregate.
Table 3 – Percentage of root canals presenting stenosis in each follow-up, distributed by molar and type of MTA.
Follow-up time Molar
74 75 84 85
% RC % RC % RC % RC
GMTA WMTA GMTA WMTA GMTA WMTA GMTA WMTA
6 months 16.7 19.4 19.2 26.1 – 22.5 18.8 30.6
12 months 41.7 41.2 72.2 61.9 62.5 41.7 58.3 71.9
18 months 58.3 62.5 72.2 64.7 87.5 54.5 83.3 73
24 months 70 82.1 83.3 73.1 100 50 100 94.4
30 months 77.8 87.5 81.3 77.3 100 50 100 93.8
36 months 75 95 91.7 93.8 100 70 100 100
42 months 75 91.7 90 90 100 100 100 100
48 months 70 90 90 100 100 – 100 100
54 months 62.5 100 90 100 100 – 100 –
60 months 66.7 100 100 – 100 – 100 –
66 months 66.7 – 100 – 100 – 100 –
72 months 50 – 100 – 100 – 100 –
78 months 50 – 100 – 100 – 100 –
84 months 100 – 100 – – – 100 –
% RC: percentage of root canals presenting stenosis.
GMTA: Grey Mineral Trioxide Aggregate.
WMTA: White Mineral Trioxide Aggregate.
j o u r n a l o f d e n t i s t r y 3 9 ( 2 0 1 1 ) 1 8 7 – 1 9 3 191
Author's personal copy
of the molars treated with Grey MTA showed pathological
signs, resulting in a 100% radiographic success. This success
rate is consistent with that found by most investigations, even
with different follow-up times.23,27,31,34 On the contrary, Holan
et al. obtained a radiographic success rate of 97% in molars
with a media follow-up time of 38.2 months.26
In molars treated with White MTA, radiographic success
was achieved in 93% of the molars. The remaining 7%
presented internal root resorption and were kept under
observation as they were asymptomatic and did not show
any signs of clinical failure, until their physiological
exfoliation. This result was similar to that obtained by
Noorollahian (94%) in a 24-month follow-up32 and higher
than the success rate obtained by Agamy et al. (80%) in a 12-
month follow-up.31
Based on the results obtained in the present investigation
for both types of MTA we can verify that the success rates
differ depending on the type of MTA: Grey MTA allowed
higher clinical and radiographic success rates. The two types
of MTA differ in composition due to the raw materials used
on their manufacture: the White material differ from the
Grey by an absence of iron.35 Also White MTA particles are
finer than Grey MTA, which would explain the different
handling of the material as explained by Camilleri et al.35
Agamy et al.31 also suggested that the difference in
composition between these two types of MTA, in particular
the presence of tetracalcium aluminoferrite in Grey MTA,
may be the cause for different results. These authors also
preformed a histological evaluation of molars treated with
either Grey or White MTA and found that, when White MTA
was used, molars presented more areas of necrosis and
inflammatory cells.31
In the present study, radiographic analysis revealed
deposition of reparative dentine in the pulp canals in most
of the cases. This was shown by dentine bridge formation and
the presence of pulp canal stenosis in radiographic images.
Dentine formation showed the presence of odontoblastic
activity which demonstrated the root canal pulp vitality and
the absence of pathology of the treated molars.24,32
Comparing dentine bridge formation between the two
types of MTA, globally, Grey MTA induced the formation of a
higher number of dentine bridges. This difference was
statistically significant (P < 0.05). Although pulp canals treated
with Grey MTA exhibited a higher percentage of pulp canal
stenosis than White MTA, this difference was not statistically
significant. On these results, our investigation agrees with
others previously published.24,32
5. Conclusions
According to the results of this study, we may conclude that
Mineral Trioxide Aggregate, Grey and White, presents a high
level of clinical and radiographic success, which allows it to be
indicated as a substitute to formocresol in pulpotomies of
primary molars without presenting any adverse results.
Although this study has shown evidence of a very good
biologic response with both types of MTA, Grey and White,
Grey MTA showed better results as it induced dentine
formation more efficiently than White MTA.
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